TMDX

Transmedics Group Stock Analysis

AI Rating

Great
  • Quality9/10
  • Growth 9/10
  • Momentum 6/10
Transmedics Group sales and earnings growth
TMDX Growth
Great
  • Revenue Y/Y 41.20%
  • EPS Y/Y 173.74%
  • FCF Y/Y 200.11%
Transmedics Group gross and profit margin trends
TMDX Profitability
Great
  • Gross margin 60.30%
  • EPS margin 16.20%
  • ROIC 11.50%
Transmedics Group net debt vs free cash flow
TMDX Risk
Good
  • Debt / Equity 1.5
  • Debt / FCF 0.4
  • Interest coverage 7.6

Transmedics Group stock volatility is in-line with the overall market. We give it a Good risk rating.

More Medical Devices stocks ↗